[1]
|
World Health Organization (2013) Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach. Geneva.
|
[2]
|
Reynolds, S.J., Nakigozi, G., Newell, K., et al. (2009) Failure of Immunologic Criteria to Appropriately Identify Antiretroviral Treatment Failure in Uganda. AIDS, 23, 697-700. https://doi.org/10.1097/QAD.0b013e3283262a78
|
[3]
|
Rawizza, H.E., Chaplin, B., Meloni, S.T., et al. (2011) Immunologic Criteria Are Poor Predictors of Virologic Outcome: Implications for HIV Treatment Monitoring in Resource-Limited Settings. Clinical Infectious Diseases, 53, 1283-1290.
https://doi.org/10.1093/cid/cir729
|
[4]
|
Davies, M.A., Boulle, A., Eley, B., et al. (2011) Accuracy of Immunological Criteria for Identifying Virological Failure in Children on Antiretroviral Therapy—The IEDEA Southern Africa Collaboration. Tropical Medicine & International Health, 16, 1367-1371. https://doi.org/10.1111/j.1365-3156.2011.02854.x
|
[5]
|
World Health Organization (2016) Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach.
|
[6]
|
UNAIDS (2017) 90-90-90: An Ambitious Treatment Target to Help End the AIDS Epidemic. https://www.unaids.org/en/resources/909090
|
[7]
|
Boerma, R.S., Boender, T.S., Bussink, A.P., et al. (2016) Suboptimal Viral Suppression Rates among HIV-Infected Children in Low- and Middle-Income Countries: A Meta-Analysis. Clinical Infectious Diseases, 63, 1645-1654.
https://doi.org/10.1093/cid/ciw645
|
[8]
|
Sithole, Z., Mbizvo, E., Chonzi, P., et al. (2018) Virological Failure among Adolescents on ART, Harare City, 2017—A Case-Control Study. BMC Infectious Diseases, 18, 469. https://doi.org/10.1186/s12879-018-3372-6
|
[9]
|
Havens, P.L. and Gibb, D.M. (2007) Increasing Antiretroviral Drug Access for Children with HIV Infection. Pediatrics, 119, 838-845.
https://doi.org/10.1542/peds.2007-0273
|
[10]
|
Lockman, S. (2007) Response to Antiretroviral Therapy after a Single, Peripartum Dose of Nevirapine. The New England Journal of Medicine, 356, 135-147.
https://doi.org/10.1056/NEJMoa062876
|
[11]
|
Sigaloff, K.C.E., Calis, J.C.J., Geelen, S.P., van Vugt, M. and Rinke de Wit, T.F. (2011) HIV-1-Resistance-Associated Mutations after Failure of First-Line Antiretroviral Treatment among Children in Resource-Poor Regions: A Systematic Review. The Lancet Infectious Diseases, 11, 769-779.
https://doi.org/10.1016/S1473-3099(11)70141-4
|
[12]
|
WHO (2018) Global Action Plan on HIV Drug Resistance 2017-2021. Progress Report.
https://www.who.int/hiv/pub/drugresistance/hivdr-action-plan-2017-2021/en
|
[13]
|
Boerma, R.S., Boender, T.S., Sigaloff, K.C., et al. (2016) High Levels of Pre-Treatment HIV Drug Resistance and Treatment Failure in Nigerian Children. Journal of the International AIDS Society, 19, 21140. https://doi.org/10.7448/IAS.19.1.21140
|
[14]
|
Tadesse, B.T., Tsai, O., Chala, A., et al. (2019) Prevalence and Correlates of Pre- Treatment HIV Drug Resistance among HIV-Infected Children in Ethiopia. Viruses, 11, 877. https://doi.org/10.3390/v11090877
|
[15]
|
Abreu, J.C., Vaz, S.N., Martins Netto, E. and Brites, C. (2017) Virological Suppression in Children and Adolescents Is Not Influenced by Genotyping, But Depends on Optimal Adherence to Antiretroviral Therapy. Brazilian Journal of Infectious Diseases, 21, 219-225. https://doi.org/10.1016/j.bjid.2017.02.001
|
[16]
|
Boerma, R.S., Sigaloff, K.C., Akanmu, A.S., Inzaule, S., Boele van Hensbroek, M., Rinke de Wit, T.F. and Calis, J.C. (2017) Alarming Increase in Pretreatment HIV Drug Resistance in Children Living in Sub-Saharan Africa: A Systematic Review and Meta-Analysis. Journal of Antimicrobial Chemotherapy, 72, 365-371.
https://doi.org/10.1093/jac/dkw463
|
[17]
|
Hamers, R.L., Schuurman, R., Sigaloff, K., Wallis, C.L., Kityo, C., Siwale, M., Mandaliya, K., Ive, P., Botes, M.E., Wellington, M. and Osibogun, A. (2012) Effect of Pretreatment HIV-1 Drug Resistance on Immunological, Virological, and Drug- Resistance Outcomes of First-Line Antiretroviral Treatment in Sub-Saharan Africa: A Multicenter Cohort Study. The Lancet Infectious Diseases, 12, 307-317.
https://doi.org/10.1016/S1473-3099(11)70255-9
|
[18]
|
Wittkop, L., Günthard, H., De Wolf, F., Dunn, D., Cozzi-Lepri, A., De Luca, A., Kücherer, C., Obel, N., Von Wyl, V., Masquelier, B. and Stephan, C. (2011) Effect of Transmitted Drug Resistance on Virological and Immunological Response to Initial Combination Antiretroviral Therapy for HIV (EuroCoord-CHAIN Joint Project): A European Multicohort Study. The Lancet Infectious Diseases, 11, 363-371.
https://doi.org/10.1016/S1473-3099(11)70032-9
|
[19]
|
World Health Organization (2015) Antiretroviral Therapy (ART) Coverage among All Age Groups. http://www.who.int/gho/hiv/epidemic_response/ART_text/en/
|
[20]
|
WHO (2014) Surveillance of HIV Drug Resistance in Adults Initiating Antiretroviral Therapy (Pre-Treatment HIV Drug Resistance). Concept Note.
http://apps.who.int/iris/bitstream/10665/112802/1/9789241507196_eng.pdf?ua=1
|
[21]
|
WHO (2016) Global Report on Early Warning Indicators of HIV Drug Resistance.
http://www.who.int/hiv/pub/drugresistance/ewi-hivdr-2016/en
|
[22]
|
UNAIDS Nigeria (2019) Start Free, Stay Free, AIDS Free: 2018 Progress Report.
|
[23]
|
UNAIDS. Nigeria. HIV and AIDS Estimates 2019 Country Fact Sheet.
|
[24]
|
Federal Ministry of Health (2016) National Implementation Plan for Scale-Up of Viral Load Testing in Nigeria.
|
[25]
|
Nigeria HIV/AIDS Indicator and Impact Survey (2019) National Summary Sheet Preliminary Findings.
|
[26]
|
Federal Ministry of Health (2016) National Guidelines for HIV Prevention Treatment and Care; National AIDS and STIs Control Programme.
|
[27]
|
Arpadi, S.M., Shiau, S., Gusmao, E.P.D. and Violari, A. (2017) Routine Viral Load Monitoring in HIV-Infected Infants and Children in Low- and Middle-Income Countries: Challenges and Opportunities. COMMENTARY. Journal of the International AIDS Society, 20, e25001. https://doi.org/10.1002/jia2.25001
|
[28]
|
Kenya Ministry of Health (2016) National AIDS/STD Control Programme (NASCOP) Dashboard.
|
[29]
|
Republic of Uganda (2016) Central Public Health Laboratories Viral Load Dashboard.
|
[30]
|
Tchouwa, G.T., Duverny, S.E., Cournil, A., et al. (2018) Nationwide Estimates of Viral Load Suppression and Acquired HIV Drug Resistance in Cameroon. E-Clinical Medicine, 1, 21-27. https://doi.org/10.1016/j.eclinm.2018.06.005
|
[31]
|
Teasdale, C.A., Sogaula, N., Yuengling, K.A., Wang, C., Mutiti, A., Arpadi, S., Nxele, M., Pepeta, L., Mogashoa, M., Rivadeneira, E.D. and Abrams, E.J. (2018) HIV Viral Suppression and Longevity among a Cohort of Children Initiating Antiretroviral Therapy in Eastern Cape, South Africa. Journal of the International AIDS Society, 21, e25168. https://doi.org/10.1002/jia2.25168
|
[32]
|
Humphrey, J.M., Genberg, B.L., Keter, A., Musick, B., Apondi, E., Gardner, A., Hogan, J.W. and Wools-Kaloustian, K. (2019) Viral Suppression among Children and Their Caregivers Living with HIV in Western Kenya. Journal of the International AIDS Society, 22, e2527. https://doi.org/10.1002/jia2.25272
|
[33]
|
Chouraya, C., Ashburn, K., Khumalo, P., et al. (2019) Association of Antiretroviral Drug Regimen with Viral Suppression in HIV-Positive Children on Antiretroviral Therapy in Eswatini. The Pediatric Infectious Disease Journal, 38, 835-839.
https://doi.org/10.1097/INF.0000000000002347
|
[34]
|
Fokam, J., Sosso, S.M., Yagai, B., Billong, S.C., Djubgang Mbadie, R.E., Kamgaing Simo, R., et al. (2019) Viral Suppression in Adults, Adolescents and Children Receiving Antiretroviral Therapy in Cameroon: Adolescents at High Risk of Virological Failure in the Era of “Test and Treat”. AIDS Research and Therapy, 16, 36.
https://doi.org/10.1186/s12981-019-0252-0
|
[35]
|
Bulage, L., Ssewanyana, I., Nankabirwa, V., et al. (2017) Factors Associated with Virological Non-Suppression among HIV-Positive Patients on Antiretroviral Therapy in Uganda, August 2014-July 2015. BMC Infectious Diseases, 17, 326.
https://doi.org/10.1186/s12879-017-2428-3
|
[36]
|
Taieb, F., Madec, Y., Cournil, A. and Delaporte, E. (2017) Virological Success after 12 and 24 Months of Antiretroviral Therapy in Sub-Saharan Africa: Comparing Results of Trials, Cohorts and Cross-Sectional Studies Using a Systematic Review and Meta-Analysis. PLoS ONE, 12, e0174767.
https://doi.org/10.1371/journal.pone.0174767
|
[37]
|
Brown, K., Williams, D.B., Kinchen, S., et al. (2018) Status of HIV Epidemic Control among Adolescent Girls and Young Women Aged 15-24 Years—Seven African Countries, 2015-2017. Morbidity and Mortality Weekly Report (MMWR), 67, 29-32.
|
[38]
|
Mavhu, W., Willis, N., Mufuka, J., et al. (2020) Effect of a Differentiated Service Delivery Model Onnvirological Failure in Adolescents with HIV in Zimbabwe (Zvandiri): A Cluster-Randomised Controlled Trial. The Lancet Global Health, 8, e264-e275.
https://doi.org/10.1016/S2214-109X(19)30526-1
|
[39]
|
Casale, M., Carlqvist, A. and Cluver, L. (2019) Recent Interventions to Improve Retention in HIV Care and Adherence to Antiretroviral Treatment among Adolescents and Youth: A Systematic Review. AIDS Patient Care STDS, 33, 237-252.
https://doi.org/10.1089/apc.2018.0320
|
[40]
|
Enane, L.A., Vreeman, R.C. and Foster, C. (2018) Retention and Adherence: Global Challenges for the Long-Term Care of Adolescents and Young Adults Living with HIV. Current Opinion in HIV and AIDS, 13, 212-219.
https://doi.org/10.1097/COH.0000000000000459
|
[41]
|
Owusu, M., Mensah, E., Enimil, A., et al. (2017) Prevalence and Risk Factors of Virological Failure among Children on Antiretroviral Therapy. BMJ Global Health, 2, A1-A67. https://doi.org/10.1136/bmjgh-2016-000260.20
|
[42]
|
Asbjornsdottir, K.H., Hughes, J.P., Wamalwa, D., Langat, A., Slyker, J.A., Okinyi, H.M., et al. (2016) Differences in Virologic and Immunologic Response to Antiretroviral Therapy among HIV-1-Infected Infants and Children. AIDS, 30, 2835-2843.
https://doi.org/10.1097/QAD.0000000000001244
|
[43]
|
Ateba Ndongo, F., Texier, G., Ida Penda, C., Tejiokem, M.C., Tetang Ndiang, S., Ndongo, J.A. and Msellati, P. (2018) Virologic Response to Early Antiretroviral Therapy in HIV-Infected Infants. The Pediatric Infectious Disease Journal, 37, 78-84. https://doi.org/10.1097/INF.0000000000001745
|
[44]
|
Salou, M., Dagnra, A.Y., Butel, C., et al. (2016) High Rates of Virological Failure and Drug Resistance in Perinatally HIV-1-Infected Children and Adolescents Receiving Lifelong Antiretroviral Therapy in Routine Clinics in Togo. Journal of the International AIDS Society, 19, 20683. https://doi.org/10.7448/IAS.19.1.20683
|
[45]
|
Kanthula, R., Rossouw, T.M., Feucht, U.D., et al. (2017) Persistence of HIV Drug Resistance among South African Children Given Nevirapine to Prevent Mother-to-Child-Transmission. AIDS, 31, 1143-1148.
https://doi.org/10.1097/QAD.0000000000001446
|
[46]
|
Kityo, C., Sigaloff, K.C., Boender, T.S., Kaudha, E., Kayiwa, J., Musiime, V., et al. (2016) HIV Drug Resistance among Children Initiating First-Line Antiretroviral Treatment in Uganda. AIDS Research and Human Retroviruses, 32, 628-635.
https://doi.org/10.1089/aid.2015.0215
|
[47]
|
Pillay, S., Bland, R.M., Lessells, R.J., Manasa, J., de Oliveira, T. and Danaviah, S. (2014) Drug Resistance in Children at Virological Failure in a Rural KwaZulu-Natal, South Africa, Cohort. AIDS Research and Therapy, 11, 3.
https://doi.org/10.1186/1742-6405-11-3
|
[48]
|
Muri, L., Gamell, A., Ntamatungiro, A.J., et al. (2017) Development of HIV Drug Resistance and Therapeutic Failure in Children and Adolescents in Rural Tanzania: An Emerging Public Health Concern. AIDS, 31, 61-70.
https://doi.org/10.1097/QAD.0000000000001273
|
[49]
|
Pinoges, L., Schramm, B., Poulet, E., Balkan, S., Szumillin, E., Ferreyra, C., et al. (2015) Risk Factors and Mortality Associated with Resistance to First-Line Antiretroviral Therapy: A Multi-Centre Cross-Sectional and Longitudinal Analysis. Journal of Acquired Immune Deficiency Syndromes, 68, 527-535.
https://doi.org/10.1097/QAI.0000000000000513
|
[50]
|
Cambiano, V., Bertagnolio, S., Jordan, M.R., Lundgren, J.D. and Phillips, A. (2013) Transmission of Drug Resistant HIV and Its Potential Impact on Mortality and Treatment Outcomes in Resource-Limited Settings. The Journal of Infectious Diseases, 207, S57-S62. https://doi.org/10.1093/infdis/jit111
|
[51]
|
Mbuagbaw, L., Aves, T., Borhan, S., Leenus, A., Jordan, M.J., Parkin, N., et al. (2017) Systematic Reviews and Meta-Analyses Used to Inform the on the Public Health Response to Pre-Treatment HIV Drug Resistance. Guidelines on the Public Health Response to Pre-Treatment HIV Drug Resistance. World Health Organization, Geneva.
|
[52]
|
Desta, A.A., Woldearegay, T.W., Futwi, N., Gebrehiwot, G.T., Gebru, G.G., Berhe, A.A., et al. (2020) HIV Virological Non-Suppression and Factors Associated with Non-Suppression among Adolescents and Adults on Antiretroviral Therapy in Northern Ethiopia: A Retrospective Study. BMC Infectious Diseases, 20, 4.
https://doi.org/10.1186/s12879-019-4732-6
|
[53]
|
Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration (2019) Incidence of Switching to Second Line Antiretroviral Therapy and Associated Factors in Children with HIV: An International Cohort Collaboration. The Lancet HIV, 6, e105-e115.
|
[54]
|
Chhim, K., Mburu, G., Tuot, S., et al. (2018) Factors Associated with Viral Non- Suppression among Adolescents Living with HIV in Cambodia: A Cross-Sectional Study. AIDS Research and Therapy, 15, 20.
https://doi.org/10.1186/s12981-018-0205-z
|
[55]
|
Rangoran, S., Colby, D.J. and Truong, G.L. (2016) Factors Associated with HIV Viral Load Suppression on Antiretroviral Therapy in Vietnam. Journal of Virus Eradication, 2, 94-101. https://doi.org/10.1016/S2055-6640(20)30466-0
|
[56]
|
Obiri-Yeboah, D., Pappoe, F., Baidoo, I., Arthur, F., Hayfron-Benjamin, A., Essien-Baidoo, S., et al. (2018) Immunologic and Virological Response to ART among HIV Infected Individuals at a Tertiary Hospital in Ghana. BMC Infectious Diseases, 18, 230. https://doi.org/10.1186/s12879-018-3142-5
|
[57]
|
Dagnra, A.Y., Vidal, N., Mensah, A., et al. (2011) High Prevalence of HIV-1 Drug Resistance among Patients on First-Line Antiretroviral Treatment in Lome, Togo. Journal of the International AIDS Society, 14, 30.
https://doi.org/10.1186/1758-2652-14-30
|
[58]
|
Messou, E., Chaix, M.L., Gabillard, D., et al. (2011) Association between Medication Possession Ratio, Virologic Failure and Drug Resistance in HIV-1-Infected Adults on Antiretroviral Therapy in Cote d’Ivoire. Journal of Acquired Immune Deficiency Syndromes, 56, 356-364. https://doi.org/10.1097/QAI.0b013e3182084b5a
|
[59]
|
Muwonga, J., Edidi, S., Butel, C., et al. (2011) Resistance to Antiretroviral Drugs in Treated and Drug-Naive Patients in the Democratic Republic of Congo. Journal of Acquired Immune Deficiency Syndromes, 57, S27-S33.
https://doi.org/10.1097/QAI.0b013e31821f596c
|
[60]
|
Abioye, A.I., Soipe, A.I., Salako, A.A., et al. (2015) Are There Differences in Disease Progression and Mortality among Male and Female HIV Patients on Antiretroviral Therapy? A Meta-Analysis of Observational Cohorts. AIDS Care, 27, 1468-1486.
https://doi.org/10.1080/09540121.2015.1114994
|
[61]
|
Beckham, S.W., Beyrer, C., Luckow, P., Doherty, M., Negussie, E.K. and Baral, S.D. (2016) Marked Sex Differences in All-Cause Mortality on Antiretroviral Therapy in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis. Journal of the International AIDS Society, 19, 21106.
https://doi.org/10.7448/IAS.19.1.21106
|
[62]
|
Penot, P., He’ma, A., Bado, G., Kabore, F., Sore, I., Sombie, D., et al. (2014) The Vulnerability of Men to Virologic Failure during Antiretroviral Therapy in a Public Routine Clinic in Burkina Faso. JIAS, 17, 18646.
https://doi.org/10.7448/IAS.17.1.18646
|
[63]
|
Novelli, S., Delobel, P., Bouchaud, O., et al. (2020) Enhanced Immuno Virological Response in Women Compared to Men after Antiretroviral Therapy Initiation during Acute and Early HIV-1 Infection: Results from a Longitudinal Study in the French ANRS Primo Cohort. Journal of the International AIDS Society, 23, e25485.
https://doi.org/10.1002/jia2.25485
|
[64]
|
Cornell, M., Schomaker, M., Garone, D.B., Giddy, J., Hoffmann, C.J., Lessells, R., et al. (2012) Gender Differences in Survival among Adult Patients Starting Antiretroviral Therapy in South Africa: A Multicentre Cohort Study. PLoS Medicine, 9, e1001304. https://doi.org/10.1371/journal.pmed.1001304
|
[65]
|
De Beaudrap, P., Thiam, M., Diouf, A., Toure-Kane, C., Ngom-Gueye, N.F., Vidal, N., et al. (2013) Risk of Virological Failure and Drug Resistance during First and Second-Line Antiretroviral Therapy in a 10-Year Cohort in Senegal: Results from the ANRS 1215 Cohort. Journal of Acquired Immune Deficiency Syndromes, 62, 381-387. https://doi.org/10.1097/QAI.0b013e31827a2a7a
|
[66]
|
Datay, M.I., Boulle, A., Mant, D. and Yudkin, P. (2010) Associations with Virologic Treatment Failure in Adults on Antiretroviral Therapy in South Africa. Journal of Acquired Immune Deficiency Syndromes, 54, 489-495.
https://doi.org/10.1097/QAI.0b013e3181d91788
|